We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Avia Health | AVIA | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.125 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.125 | 2.125 |
| Top Posts |
|---|
Posted at 10/11/2013 19:54 by drunken sailor KNIGEL,Drop me a line at drunken.sailor1@hotm You need to be aware that despite the pretense of people like GI/BG/TB that it is just one person with multiple aliases, actually there are a lot of people who feel the same as I do and post accordingly, TB has through his arrogance and deceptions built up a truly international following of people who have had enough of his brand of deception. I appreciate you want Cientifica to be a success so you can recoup some of your losses. Nothing would please me more than to see that happen. Unfortunately there is no realistic prospect of that happening while TB is involved to which his long history of failures is testament. If Tim Harper does not get rid of him very soon, then that tells you all you need to know about Tim Harper. Happy to chat more by direct e-mail |
Posted at 10/11/2013 19:15 by knigel Were did this feud/argument/disagrTop Info is arranging drinks on the 5th December (see CR thread) in London and all posters are invited. Perhaps a few here should arrange to go and discuss their disagreements face to face? |
Posted at 09/11/2013 12:10 by graphene investor For once you are right yawnsome in that the txo announcement does not make any reference to graphene or avia, but I never said it did. am afraid your detective skills are just as lacking as my information was from a phone call with someone who had been at OB and heard TB speak at 10.30am which was before my post and who asked him about cientifica at the end but i had assumed the beginniing. whilst he made reference to graphene the announcement and presentation doesn't really link the two and in the end had nothing to do with cientifica |
Posted at 08/11/2013 18:51 by knigel PLEASE NOTE THAT AVIA IS NOW HISTORY!THERE IS A NEW TICKER (see rns) FOR THIS CASH SHELL COMPANY TO DISCUSS IT GOING FORWARD (hopefully without mentioning TXO too often lol) |
Posted at 08/11/2013 15:52 by yarsan GI, very interesting. Contrary to your claim, the TXO announcement does NOT make any reference at all to graphene or Avia, and certainly doesn't provide any "links" to where TXO may be heading in the sector.However TB's Oilbarrel presentation, which was made AFTER your post, DOES have "links [to] what they are doing to graphene in the oil and gas sector." Odd that you'd know what was going to be in the presentation ahead of time. LLOLLOLLOL You really must try and keep track of things better. |
Posted at 30/10/2013 10:52 by ih_237920 GI, you are absolutely correct. I simply mixed quotes from two different nonsensical posts into my one reply, without making it completely clear who said what. No need for me to edit my posts (unlike you), I have no problem admitting the occasional slip up.It was indeed encarter who said in his #835 "AVIA is the only way to have a direct investment" in graphene. The mindless ramping and sycophantic praise of the CEO had me confused, I'll admit. My questions remain unanswered, however: -------------------- Uhhh, you ARE aware this makes absolutely no sense, aren't you? "there is something of value or why else would you be tryng to attack it." How exactly is Avia "the only way to have a direct investment" in Graphene? Have they announced ANY investments yet? Do they have ANY money? Your man crush on Tim Harper aside... all we have is a nearly failed placing, the prospect of immediate further dilution, and some sketchy characters running the show. No "graphene" investments at all, I'm afraid. |
Posted at 24/6/2013 12:49 by 29howard It's just so grim out there, so many small caps struggling for their life.RNS Number : 7067H Avia Health Informatics PLC 24 June 2013 Avia Health Informatics Plc ("Avia" or "the Company") Suspension from trading of securities on AIM Further to the announcement made by the Company on 1 March 2013, Avia has experienced continued ordering delays in the NHS which has resulted in a deferral of expected revenues. In addition the Company has experienced a delay in entering into an agreement to licence the Company's technology to a third party. This licence agreement was expected to be entered into by the end of June 2013. These factors will lead to a significant working capital shortfall and the directors now believe that without an immediate injection of further capital the Company will be unable to meet its current obligations. The Company has therefore requested the suspension of its shares from trading on AIM, pending clarification of its financial position. The Directors believe that the positive case for its technology remains valid and are seeking the necessary capital to overcome the working capital shortfall. However, should the required capital not be found, it is likely that the Company, or its principal creditors, will seek the appointment of an administrator. Further announcements will be made as and when appropriate. 24 June 2013 |
Posted at 24/6/2013 12:48 by christianf12 Further rnsSo they have noticed they need funding. Don't see a problem as long as ASW still supportive. Licence agreement sounds interesting, they were obviously expecting immediate revenue from it. Wonder how long this will drag on for. Avia Health Infrmtcs Statement re. Suspension RNS Number : 7067H Avia Health Informatics PLC 24 June 2013 Avia Health Informatics Plc ("Avia" or "the Company") Suspension from trading of securities on AIM Further to the announcement made by the Company on 1 March 2013, Avia has experienced continued ordering delays in the NHS which has resulted in a deferral of expected revenues. In addition the Company has experienced a delay in entering into an agreement to licence the Company's technology to a third party. This licence agreement was expected to be entered into by the end of June 2013. These factors will lead to a significant working capital shortfall and the directors now believe that without an immediate injection of further capital the Company will be unable to meet its current obligations. The Company has therefore requested the suspension of its shares from trading on AIM, pending clarification of its financial position. The Directors believe that the positive case for its technology remains valid and are seeking the necessary capital to overcome the working capital shortfall. However, should the required capital not be found, it is likely that the Company, or its principal creditors, will seek the appointment of an administrator. Further announcements will be made as and when appropriate. 24 June 2013 Enquiries: Avia Health Informatics Plc +44 (0) 1494 618 503 Jeremy Dale, Chief Executive Tim Morris, Managing Director Allenby Capital (Nominated Adviser and Broker) +44 (0) 20 3328 5656 Nick Naylor Mark Connelly |
Posted at 24/6/2013 12:05 by charmer1_23 Oh Dear, not looking good peeps:AIM Suspension - AVIA Health Informatics plc Date : 24/06/2013 @ 12:00 Source : UK Regulatory (RNS & others) Stock : Avia Health (AVIA) Quote : 7.25 -0.5 (-6.45%) @ 11:32 HOME » LSE » LSE » Avia Health share price AIM Suspension - AVIA Health Informatics plc Alert TIDMAVIA RNS Number : 7017H AIM 24 June 2013 NOTICE 24/06/2013 12:00am TEMPORARY SUSPENSION OF TRADING ON AIM AVIA HEALTH INFORMATICS PLC At the request of the company trading on AIM for the under-mentioned securities has been temporarily suspended from 24/06/2013 12:00am, pending clarification of the Company's financial position. Ordinary shares of 0.5p each, fully paid (B4YSYV6)(GB00B4YSYV If you have any queries relating to the above, please contact the company's nominated adviser on 020 3328 5656. This information is provided by RNS The company news service from the London Stock Exchange END EXCSEEFSLFDSEIM |
Posted at 23/5/2013 21:50 by 29howard This to me has great potential, the orders may be small given the size of the business but there is unlimited growth and with a micro market cap any orderswill benefit the shareprice. Avia Health Informatics PLC User of Odyssey CareAssess wins award Alert TIDMAVIA Avia Health Informatics PLC 14 March 2013 Eric Williams House wins the Early Intervention and Prevention award at the Lang & Buisson Independent Specialist Care Awards for its use of Odyssey CareAssess Avia (AIM: AVIA), the developer and provider of clinical decision support and referral facilitation software, via its wholly owned subsidiary, Plain Healthcare is proud to announce that Eric Williams House, a local government funded care home in Coventry, won the prestigious Early Intervention and Prevention award at the national Lang & Buisson Independent Specialist Care Awards on the 12(th) March, for its use of Odyssey CareAssess. Plain Healthcare, has been working with Eric Williams House and the Godiva Clinical Commissioning Group on the development of Odyssey CareAssess since October 2011. Eric Williams House is a 43 bedded care home for the elderly mentally infirm which historically placed significant demands on the 999 ambulance service and the local emergency department, as well as the out of hours service. Odyssey CareAssess was introduced to support resident centred assessments of health care needs. The Odyssey CareAssess software, specifically designed for care home residents and carers, uses intuitive touchscreen technology, enabling individual problems to be identified, assessed and managed at the earliest stage. Carers and residents are supported in history taking and appropriate outcome generation. The change in process that Odyssey CareAssess enabled has increased staff confidence, knowledge and ensured quality. Many more problems are now identified earlier. When intervention is needed, it is clear to the staff what this might be and it gives a clear timeframe for them to follow. Residents are more frequently effectively managed in-house with the right advice and follow up support, and when outside intervention is required, a robust history can be sent in advance to aid informed decision making by health professionals as to the urgency of next steps. This has enabled early and appropriate intervention regarding, for example, suspected infections - maintaining optimum levels of health for residents. Staff at Eric Williams House quickly embraced the change and the tablet has become a crucial part of the carer toolkit, portable and easy to use with an average of eight uses per day rising to 20 on occasions. Key Outcomes -- 42% reduction in Emergency Department attendance maintained over a 12 month period (verified statistics) -- GP attendance reduced by 75% (unverified) -- Staff, residents and families confident of highest quality care -- Educational structure develops carer knowledge and skills with every use -- Robust records reflecting best practice and current clinical evidence are maintained The Independent Specialist Care Awards draws attention to the best performing private and voluntary sector providers working in the provision of social care services for adults with learning or physical disabilities or mental health conditions whether that be in residential care, homecare or specialist hospitals. Professor Jeremy Dale, Chief Executive of Avia Health Informatics Plc, commented: "We are delighted for Eric Williams House. Their use of Odyssey CareAssess has helped us to develop a robust assessment tool that enables early intervention and appropriate care of the most vulnerable people. To receive an award like this further justifies our commitment to providing high quality clinical decision support that benefits patients, healthcare professionals and service providers alike." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
